{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PRECISE&page=2", "query": { "intervention": "PRECISE", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PRECISE&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-03T10:44:09.892Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01616342", "title": "Management of Chronic Pain in Military Patients With Injuries Sustained During Active Duty", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Extremity Injury" ], "interventions": [ { "name": "Spinal cord stimulator", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Sceptor Pain Foundation", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 180, "start_date": "2011-12", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2012-06-11", "last_synced_at": "2026-09-03T10:44:09.892Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01616342" }, { "nct_id": "NCT04358705", "title": "C-FLASH (Cigarillo Flavor and Abuse Liability, Attention, and Substitution in youtH)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Smoking Behaviors" ], "interventions": [ { "name": "Aim 1: Online survey", "type": "OTHER" }, { "name": "Eye Tracking Activity", "type": "BEHAVIORAL" }, { "name": "Eye tracking survey", "type": "OTHER" }, { "name": "Online Experimental Marketplace (ETM)", "type": "BEHAVIORAL" }, { "name": "Aim 3 survey", "type": "OTHER" }, { "name": "Cognitive Interviews", "type": "OTHER" }, { "name": "Supplemental Aim 1 Interviews", "type": "OTHER" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "28 Years", "sex": "ALL", "summary": "16 Years to 28 Years" }, "enrollment_count": 658, "start_date": "2020-05-29", "completion_date": "2023-02-10", "has_results": false, "last_update_posted_date": "2024-03-06", "last_synced_at": "2026-09-03T10:44:09.892Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04358705" }, { "nct_id": "NCT07579156", "title": "TearCare in Young Adults", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Meibomian Gland Dysfunction (Disorder)" ], "interventions": [ { "name": "TearCare®", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "29 Years", "sex": "ALL", "summary": "18 Years to 29 Years" }, "enrollment_count": 45, "start_date": "2026-08-01", "completion_date": "2027-12-01", "has_results": false, "last_update_posted_date": "2026-05-11", "last_synced_at": "2026-09-03T10:44:09.892Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT07579156" }, { "nct_id": "NCT00966095", "title": "PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Prostate Cancer" ], "interventions": [], "intervention_types": [], "sponsor": "Source MDx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "MALE", "summary": "40 Years and older · Male only" }, "enrollment_count": 1200, "start_date": "2009-12", "completion_date": null, "has_results": false, "last_update_posted_date": "2010-11-25", "last_synced_at": "2026-09-03T10:44:09.892Z", "location_count": 17, "location_summary": "San Bernardino, California • Denver, Colorado • Chicago, Illinois + 11 more", "locations": [ { "city": "San Bernardino", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00966095" }, { "nct_id": "NCT06745076", "title": "Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Advanced Hodgkin Lymphoma", "Classic Hodgkin Lymphoma", "Lugano Classification Stage III Hodgkin Lymphoma AJCC v8", "Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Dacarbazine", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Echocardiography Test", "type": "PROCEDURE" }, { "name": "Multigated Acquisition Scan", "type": "PROCEDURE" }, { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Vinblastine", "type": "DRUG" }, { "name": "Questionnaire", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BIOLOGICAL", "OTHER" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2025-03-06", "completion_date": "2033-01-03", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-09-03T10:44:09.892Z", "location_count": 6, "location_summary": "Irvine, California • Palo Alto, California • Boston, Massachusetts + 3 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06745076" }, { "nct_id": "NCT05455814", "title": "Brain Health With Inner Engineering Meditation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Meditation", "Brain; Agenesis" ], "interventions": [ { "name": "Shambhavi Madamudra Kriya", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Beth Israel Deaconess Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "20 Years to 65 Years" }, "enrollment_count": 77, "start_date": "2023-01-06", "completion_date": "2025-12-17", "has_results": false, "last_update_posted_date": "2026-05-14", "last_synced_at": "2026-09-03T10:44:09.892Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05455814" }, { "nct_id": "NCT05752942", "title": "Precision-Based Approach to Matching Evidence-Based Interventions to Students With Externalizing Behaviors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Problem;Behaviour;Child" ], "interventions": [ { "name": "Student Intervention Matching System (SIMS)", "type": "BEHAVIORAL" }, { "name": "group-based social skills training", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Iowa", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "9 Years to 12 Years" }, "enrollment_count": 51, "start_date": "2018-08-25", "completion_date": "2018-12-01", "has_results": false, "last_update_posted_date": "2023-03-03", "last_synced_at": "2026-09-03T10:44:09.892Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05752942" }, { "nct_id": "NCT03573401", "title": "Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Superficial Basal Cell Carcinoma" ], "interventions": [ { "name": "Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT)", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient)", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Biofrontera Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 187, "start_date": "2018-09-25", "completion_date": "2029-02", "has_results": true, "last_update_posted_date": "2026-01-14", "last_synced_at": "2026-09-03T10:44:09.892Z", "location_count": 18, "location_summary": "Phoenix, Arizona • Fountain Valley, California • San Diego, California + 14 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Fountain Valley", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Greenwood Village", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03573401" }, { "nct_id": "NCT06937671", "title": "Randomized Trial of Cold EMR Compared to Hybrid Cold EMR.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Polyp of Colon", "Endoscopic Mucosal Resection" ], "interventions": [ { "name": "Cold EMR", "type": "PROCEDURE" }, { "name": "Hybrid EMR", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 194, "start_date": "2025-05-01", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-07-29", "last_synced_at": "2026-09-03T10:44:09.892Z", "location_count": 2, "location_summary": "Weston, Florida • Cleveland, Ohio", "locations": [ { "city": "Weston", "state": "Florida" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06937671" }, { "nct_id": "NCT04129931", "title": "PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "MCT", "type": "DRUG" }, { "name": "Clazakizumab", "type": "DRUG" }, { "name": "Broncho-Vaxom", "type": "DRUG" }, { "name": "Imatinib Mesylate", "type": "DRUG" }, { "name": "Cavosonstat", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 950, "start_date": "2019-12-19", "completion_date": "2025-03-19", "has_results": true, "last_update_posted_date": "2026-04-01", "last_synced_at": "2026-09-03T10:44:09.892Z", "location_count": 29, "location_summary": "Scottsdale, Arizona • Tucson, Arizona • Sacramento, California + 17 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04129931" } ] }